Autopsy report · NCT00137293
Study Evaluating GAP-486 in Heart Rhythm
Cause of deathNo reason given
Life of this trial
- Registered 3 months before it started.
- Ran for about 11 months before it stopped.
- 30 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Sponsor type
- Industry
- Conditions
- Arrhythmia
- Interventions
- GAP-486 (ZP-123); 0.9% Sodium Chloride, USP
- Participants
- 30
- Sites
- 7
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.